{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:16:23Z","timestamp":1793812583195,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>A causal role of the complement system in Alzheimer's disease pathogenesis has been postulated based on the identification of different activated components up to the membrane attack complex at amyloid plaques in brain. However, histological studies of amyloid plaque bearing APP transgenic mice provided only evidence for an activation of the early parts of the complement cascade. To better understand the contribution of normal aging and amyloid deposition to the increase in complement activation we performed a detailed characterization of the expression of the major mouse complement components.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>APP23 mice expressing human APP751 with the Swedish double mutation as well as C57BL\/6 mice were used at different ages. mRNA was quantified by Realtime PCR and the age- as well as amyloid induced changes determined. The protein levels of complement C1q and C3 were analysed by Western blotting. Histology was done to test for amyloid plaque association and activation of the complement cascade.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>High mRNA levels were detected for C1q and some inhibitory complement components. The expression of most activating components starting at C3 was low. Expression of C1q, C3, C4, C5 and factor B mRNA increased with age in control C57BL\/6 mice. C1q and C3 mRNA showed a substantial additional elevation during amyloid formation in APP23 mice. This increase was confirmed on the protein level using Western blotting, whereas immunohistology indicated a recruitment of complement to amyloid plaques up to the C3 convertase.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Early but not late components of the mouse complement system show an age-dependent increase in expression. The response to amyloid deposition is comparatively smaller. The low expression of C3 and C5 and failure to upregulate C5 and downstream components differs from human AD brain and likely contributes to the lack of full complement activation in APP transgenic mice.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1742-2094-6-35","type":"journal-article","created":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T19:13:46Z","timestamp":1258485226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Expression of complement system components during aging and amyloid deposition in APP transgenic mice"],"prefix":"10.1186","volume":"6","author":[{"given":"Julia","family":"Reichwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Wiederhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Staufenbiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,17]]},"reference":[{"key":"205_CR1","volume-title":"Immunology","author":"RA Goldsby","year":"2003","unstructured":"Goldsby RA, Kindt TJ, Osborne BA, Kuby J: Immunology. 2003, New York: W.H. Freeman and Company"},{"key":"205_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/10454411950060020301","volume":"6","author":"SR Barnum","year":"1995","unstructured":"Barnum SR: Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med. 1995, 6: 132-146. 10.1177\/10454411950060020301.","journal-title":"Crit Rev Oral Biol Med"},{"key":"205_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0167-5699(96)20028-F","volume":"17","author":"BP Morgan","year":"1996","unstructured":"Morgan BP, Gasque P: Expression of complement in the brain: role in health and disease. Immunol Today. 1996, 17: 461-466. 10.1016\/0167-5699(96)20028-F.","journal-title":"Immunol Today"},{"key":"205_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0006-8993(97)00850-0","volume":"769","author":"Y Shen","year":"1997","unstructured":"Shen Y, Li R, McGeer EG, McGeer PL: Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 1997, 769: 391-395. 10.1016\/S0006-8993(97)00850-0.","journal-title":"Brain Res"},{"key":"205_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T: Inflammation and Alzheimer's disease. Neurobiol Aging. 2000, 21: 383-421. 10.1016\/S0197-4580(00)00124-X.","journal-title":"Neurobiol Aging"},{"key":"205_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.pneurobio.2003.08.001","volume":"70","author":"Y Shen","year":"2003","unstructured":"Shen Y, Meri S: Yin and Yang: complement activation and regulation in Alzheimer's disease. Prog Neurobiol. 2003, 70: 463-472.","journal-title":"Prog Neurobiol"},{"key":"205_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0197-4580(01)00301-3","volume":"22","author":"AJ Tenner","year":"2001","unstructured":"Tenner AJ: Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events. Neurobiol Aging. 2001, 22: 849-861. 10.1016\/S0197-4580(01)00301-3.","journal-title":"Neurobiol Aging"},{"key":"205_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0304-3940(01)01842-0","volume":"305","author":"Y Shen","year":"2001","unstructured":"Shen Y, Lue L, Yang L, Roher A, Kuo Y, Strohmeyer R, Goux WJ, Lee V, Johnson GV, Webster SD, Cooper NR, Bradt B, Rogers J: Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci Lett. 2001, 305: 165-168. 10.1016\/S0304-3940(01)01842-0.","journal-title":"Neurosci Lett"},{"key":"205_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/exnr.1996.0043","volume":"138","author":"A Afagh","year":"1996","unstructured":"Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ: Localization and cell association of C1q in Alzheimer's disease brain. Exp Neurol. 1996, 138: 22-32. 10.1006\/exnr.1996.0043.","journal-title":"Exp Neurol"},{"key":"205_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0169-328X(93)90097-9","volume":"18","author":"L Brachova","year":"1993","unstructured":"Brachova L, Lue LF, Schultz J, el Rashidy R, Rogers J: Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease. Brain Res Mol Brain Res. 1993, 18: 329-334. 10.1016\/0169-328X(93)90097-9.","journal-title":"Brain Res Mol Brain Res"},{"key":"205_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF02890024","volume":"56","author":"P Eikelenboom","year":"1989","unstructured":"Eikelenboom P, Hack CE, Rozemuller JM, Stam FC: Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989, 56: 259-262. 10.1007\/BF02890024.","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"205_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-5-9","volume":"5","author":"DA Loeffler","year":"2008","unstructured":"Loeffler DA, Camp DM, Bennett DA: Plaque complement activation and cognitive loss in Alzheimer's disease. Journal of Neuroinflammation. 2008, 5: 9-10.1186\/1742-2094-5-9.","journal-title":"Journal of Neuroinflammation"},{"key":"205_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0304-3940(89)90843-4","volume":"107","author":"PL McGeer","year":"1989","unstructured":"McGeer PL, Akiyama H, Itagaki S, McGeer EG: Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett. 1989, 107: 341-346. 10.1016\/0304-3940(89)90843-4.","journal-title":"Neurosci Lett"},{"key":"205_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0006-8993(97)00849-4","volume":"769","author":"K Terai","year":"1997","unstructured":"Terai K, Walker DG, McGeer EG, McGeer PL: Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res. 1997, 769: 385-390. 10.1016\/S0006-8993(97)00849-4.","journal-title":"Brain Res"},{"key":"205_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0197-4580(97)00042-0","volume":"18","author":"S Webster","year":"1997","unstructured":"Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J: Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging. 1997, 18: 415-421. 10.1016\/S0197-4580(97)00042-0.","journal-title":"Neurobiol Aging"},{"key":"205_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","volume":"154","author":"K Yasojima","year":"1999","unstructured":"Yasojima K, Schwab C, McGeer EG, McGeer PL: Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am J Pathol. 1999, 154: 927-936.","journal-title":"Am J Pathol"},{"key":"205_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","volume":"87","author":"A Salminen","year":"2009","unstructured":"Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T: Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol. 2009, 87: 181-194. 10.1016\/j.pneurobio.2009.01.001.","journal-title":"Prog Neurobiol"},{"key":"205_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1084\/jem.188.3.431","volume":"188","author":"BM Bradt","year":"1998","unstructured":"Bradt BM, Kolb WP, Cooper NR: Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med. 1998, 188: 431-438. 10.1084\/jem.188.3.431.","journal-title":"J Exp Med"},{"key":"205_CR19","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.152.10.5050","volume":"152","author":"H Jiang","year":"1994","unstructured":"Jiang H, Burdick D, Glabe CG, Cotman CW, Tenner AJ: beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol. 1994, 152: 5050-5059.","journal-title":"J Immunol"},{"key":"205_CR20","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","volume":"89","author":"J Rogers","year":"1992","unstructured":"Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, et al: Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci USA. 1992, 89: 10016-10020. 10.1073\/pnas.89.21.10016.","journal-title":"Proc Natl Acad Sci USA"},{"key":"205_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.expneurol.2004.03.016","volume":"188","author":"C Schwab","year":"2004","unstructured":"Schwab C, Hosokawa M, McGeer PL: Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol. 2004, 188: 52-64. 10.1016\/j.expneurol.2004.03.016.","journal-title":"Exp Neurol"},{"key":"205_CR22","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0002-9440(10)64085-0","volume":"158","author":"Y Matsuoka","year":"2001","unstructured":"Matsuoka Y, Picciano M, Malester B, Lafrancois J, Zehr C, Daeschner JM, Olschowka JA, Fonseca MI, O'Banion MK, Tenner AJ, Lemere CA, Duff K: Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol. 2001, 158: 1345-1354.","journal-title":"Am J Pathol"},{"key":"205_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0197-4580(99)00020-2","volume":"20","author":"SD Webster","year":"1999","unstructured":"Webster SD, Tenner AJ, Poulos TL, Cribbs DH: The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation. Neurobiol Aging. 1999, 20: 297-304. 10.1016\/S0197-4580(99)00020-2.","journal-title":"Neurobiol Aging"},{"key":"205_CR24","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1016\/j.molimm.2008.02.022","volume":"45","author":"M Li","year":"2008","unstructured":"Li M, Ager RR, Fraser DA, Tjokro NO, Tenner AJ: Development of a humanized C1q A chain knock-in mouse: Assessment of antibody independent beta-amyloid induced complement activation. Molecular Immunology. 2008, 45: 3244-3252. 10.1016\/j.molimm.2008.02.022.","journal-title":"Molecular Immunology"},{"key":"205_CR25","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","volume":"24","author":"MI Fonseca","year":"2004","unstructured":"Fonseca MI, Zhou J, Botto M, Tenner AJ: Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J Neurosci. 2004, 24: 6457-6465. 10.1523\/JNEUROSCI.0901-04.2004.","journal-title":"J Neurosci"},{"key":"205_CR26","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","volume":"28","author":"M Maier","year":"2008","unstructured":"Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA: Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci. 2008, 28: 6333-6341. 10.1523\/JNEUROSCI.0829-08.2008.","journal-title":"J Neurosci"},{"key":"205_CR27","doi-asserted-by":"publisher","first-page":"10837","DOI":"10.1073\/pnas.162350199","volume":"99","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Yan F, Lin AH, Lambris JD, Alexander JJ, Quigg RJ, Masliah E: Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci USA. 2002, 99: 10837-10842. 10.1073\/pnas.162350199.","journal-title":"Proc Natl Acad Sci USA"},{"key":"205_CR28","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, O'Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, Paul SM, Aronow BJ, Holtzman DM: Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 2002, 99: 10843-10848. 10.1073\/pnas.162228299.","journal-title":"Proc Natl Acad Sci USA"},{"key":"205_CR29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1172\/JCI9037","volume":"106","author":"L McLaughlin","year":"2000","unstructured":"McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, Florio CJ, Groen PA, Witt SA, Kimball TR, Witte DP, Harmony JA, Aronow BJ: Apolipoprotein J\/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest. 2000, 106: 1105-1113. 10.1172\/JCI9037.","journal-title":"J Clin Invest"},{"key":"205_CR30","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","volume":"183","author":"MI Fonseca","year":"2009","unstructured":"Fonseca MI, Ager RR, Chu SH, Yazan O, Sanderson SD, Laferla FM, Taylor SM, Woodruff TM, Tenner AJ: Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease. Journal of Immunology. 2009, 183: 1375-1383. 10.4049\/jimmunol.0901005.","journal-title":"Journal of Immunology"},{"key":"205_CR31","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B: Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA. 1997, 94: 13287-13292. 10.1073\/pnas.94.24.13287.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"125","key":"205_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-1759(89)90088-4","volume":"20","author":"GL Ong","year":"1989","unstructured":"Ong GL, Mattes MJ: Mouse strains with typical mammalian levels of complement activity. J Immunol Methods. 1989, 20 (125): 147-158. 10.1016\/0022-1759(89)90088-4.","journal-title":"J Immunol Methods"},{"key":"205_CR33","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1101\/gr.6.10.986","volume":"6","author":"CA Heid","year":"1996","unstructured":"Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative PCR. Genome Res. 1996, 6: 986-994. 10.1101\/gr.6.10.986.","journal-title":"Genome Res"},{"key":"205_CR34","volume-title":"Applied Biosystems","author":"Biosystems Applied","year":"2004","unstructured":"Applied Biosystems: Amplification Efficiency of TaqMan Gene Expression Assays. Applied Biosystems. 2004"},{"key":"205_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1084\/jem.181.1.151","volume":"181","author":"YU Kim","year":"1995","unstructured":"Kim YU, Kinoshita T, Molina H, Hourcade D, Seya T, Wagner LM, Holers VM: Mouse complement regulatory protein Crry\/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med. 1995, 181: 151-159. 10.1084\/jem.181.1.151.","journal-title":"J Exp Med"},{"key":"205_CR36","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.4049\/jimmunol.151.8.4295","volume":"151","author":"B Li","year":"1993","unstructured":"Li B, Sallee C, Dehoff M, Foley S, Molina H, Holers VM: Mouse Crry\/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol. 1993, 151: 4295-4305.","journal-title":"J Immunol"},{"key":"205_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-1759(92)90210-K","volume":"154","author":"GL Ong","year":"1992","unstructured":"Ong GL, Baker AE, Mattes MJ: Analysis of high complement levels in Mus hortulanus and BUB mice. J Immunol Methods. 1992, 154: 37-45. 10.1016\/0022-1759(92)90210-K.","journal-title":"J Immunol Methods"},{"key":"205_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-2-1","volume":"2","author":"R Fan","year":"2005","unstructured":"Fan R, Tenner AJ: Differential regulation of Abeta42-induced neuronal C1q synthesis and microglial activation. J Neuroinflammation. 2005, 2: 1-10.1186\/1742-2094-2-1.","journal-title":"J Neuroinflammation"},{"key":"205_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0002-9440(10)63945-4","volume":"158","author":"KD Bornemann","year":"2001","unstructured":"Bornemann KD, Wiederhold KH, Pauli C, Ermini F, Stalder M, Schnell L, Sommer B, Jucker M, Staufenbiel M: Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol. 2001, 158: 63-73.","journal-title":"Am J Pathol"},{"key":"205_CR40","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.molimm.2005.10.004","volume":"43","author":"I Osmers","year":"2006","unstructured":"Osmers I, Szalai AJ, Tenner AJ, Barnum SR: Complement in BuB\/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated. Mol Immunol. 2006, 43: 1722-1725. 10.1016\/j.molimm.2005.10.004.","journal-title":"Mol Immunol"},{"key":"205_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0169-328X(00)00149-2","volume":"81","author":"R Strohmeyer","year":"2000","unstructured":"Strohmeyer R, Shen Y, Rogers J: Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. Brain Res Mol Brain Res. 2000, 81: 7-18. 10.1016\/S0169-328X(00)00149-2.","journal-title":"Brain Res Mol Brain Res"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-6-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T15:50:25Z","timestamp":1685202625000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-6-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,17]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["205"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-6-35","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,17]]},"assertion":[{"value":"13 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"35"}}